CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We received an updated WNV package insert; please note the manufacturer and license number has been ...